These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29334320)

  • 1. Human dopamine transporter: the first implementation of a combined in silico/in vitro approach revealing the substrate and inhibitor specificities.
    Djikic T; Martí Y; Spyrakis F; Lau T; Benedetti P; Davey G; Schloss P; Yelekci K
    J Biomol Struct Dyn; 2019 Feb; 37(2):291-306. PubMed ID: 29334320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter.
    Cheng MH; Bahar I
    Structure; 2015 Nov; 23(11):2171-81. PubMed ID: 26481814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.
    Sun WL; Quizon PM; Yuan Y; Zhang W; Ananthan S; Zhan CG; Zhu J
    Sci Rep; 2017 Jun; 7(1):3694. PubMed ID: 28623359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-quality homology model for the human dopamine transporter validated for drug design purposes.
    Castellana MC; Castellar Montes A; Sprague JE; Mahfouz TM
    Chem Biol Drug Des; 2019 May; 93(5):700-711. PubMed ID: 30721576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.
    Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K
    ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
    Indarte M; Madura JD; Surratt CK
    Proteins; 2008 Feb; 70(3):1033-46. PubMed ID: 17847094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Structural Basis of the Activity Cliff in Modafinil-Based Dopamine Transporter Inhibitors.
    Lee KH; Camacho-Hernandez GA; Newman AH; Shi L
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport.
    Quizon PM; Sun WL; Yuan Y; Midde NM; Zhan CG; Zhu J
    Sci Rep; 2016 Dec; 6():39048. PubMed ID: 27966610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer.
    Gedeon PC; Indarte M; Surratt CK; Madura JD
    Proteins; 2010 Mar; 78(4):797-811. PubMed ID: 19899168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
    Doolen S; Zahniser NR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake.
    Yuan Y; Quizon PM; Sun WL; Yao J; Zhu J; Zhan CG
    Sci Rep; 2016 Jun; 6():27314. PubMed ID: 27250920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Assessment of the Energetics of Dopamine Translocation by Human Dopamine Transporter.
    Cheng MH; Kaya C; Bahar I
    J Phys Chem B; 2018 May; 122(21):5336-5346. PubMed ID: 29232131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters.
    Merchant BA; Madura JD
    J Mol Graph Model; 2012 Sep; 38():1-12. PubMed ID: 23079638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.
    Yuan Y; Huang X; Midde NM; Quizon PM; Sun WL; Zhu J; Zhan CG
    ACS Chem Neurosci; 2015 Apr; 6(4):658-665. PubMed ID: 25695767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation.
    Navratna V; Tosh DK; Jacobson KA; Gouaux E
    PLoS One; 2018; 13(7):e0200085. PubMed ID: 29965988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the Search for New Dopamine Transporter Inhibitors.
    Gryzło B; Zaręba P; Malawska K; Jakubowska A; Kulig K
    Curr Med Chem; 2015; 22(28):3255-77. PubMed ID: 26264922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode-Selective Raman Imaging of Dopamine-Human Dopamine Transporter Interaction in Live Cells.
    Silwal AP; Lu HP
    ACS Chem Neurosci; 2018 Dec; 9(12):3117-3127. PubMed ID: 30024721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ; Neve RL; Janowsky A; Neve KA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the human dopamine transporter and mechanisms of inhibition.
    Srivastava DK; Navratna V; Tosh DK; Chinn A; Sk MF; Tajkhorshid E; Jacobson KA; Gouaux E
    Nature; 2024 Aug; 632(8025):672-677. PubMed ID: 39112705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.